Morgan Stanley has reported owning 5.7% of AGIOS Pharmaceuticals, indicating strong interest in the pharmaceutical sector.
| Name | AGIOS PHARMACEUTICALS, INC. |
|---|---|
| CIK | 0001439222 |
| Tickers | AGIO |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-649-8600 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Morgan Stanley has reported owning 5.7% of AGIOS Pharmaceuticals, indicating strong interest in the pharmaceutical sector.
AGIOS Pharmaceuticals releases Q3 earnings report, detailing financial performance and operational updates, impacting investor confidence in the pharmaceutical sector.
Agios Pharmaceuticals announced significant revenue growth in Q3 2026, driven by its thalassemia treatment AQVESME and prepares for FDA review for sickle cell disease.
1307 filing rows loaded from submissions recent; extra archives: CIK0001439222-submissions-001.json (306 filings, 2008-07-01 to 2016-01-03).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128410 | 005-87570 | 261561808 | 34 | 21141 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-004571 | 005-87570 | 261560456 | 34 | 10560 | |||
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000895421-26-000341 | 005-87570 | 261553962 | 34 | 7907 | |||
| 2026-11-05 | 10-Q | 10-Q | 0001439222-26-000131 | 001-36014 | 261525223 | 34 | 6640607 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001439222-26-000129 | 001-36014 | 261524596 | 34 | 325135 | 1 | 1 |
| 2026-10-28 | 4 | FORM 4 | 0001439222-26-000124 | 8970 | ||||||
| 2026-10-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010399 | 001-36014 | 261486045 | 33 | 6865 | |||
| 2026-10-23 | 4 | FORM 4 | 0001439222-26-000122 | 13738 | ||||||
| 2026-10-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010371 | 001-36014 | 261479306 | 33 | 6178 | |||
| 2026-10-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010353 | 001-36014 | 261476803 | 33 | 5495 | |||
| 2026-08-06 | 4 | FORM 4 | 0001439222-26-000120 | 5348 | ||||||
| 2026-08-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007592 | 001-36014 | 261238651 | 33 | 6381 | |||
| 2026-08-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000908834-26-000367 | 005-87570 | 261230546 | 34 | 47408 | |||
| 2026-07-30 | 10-Q | 10-Q | 0001439222-26-000118 | 001-36014 | 261220651 | 34 | 6519319 | 1 | 1 | |
| 2026-07-30 | 8-K | 8-K | 2.02,9.01 | 0001439222-26-000115 | 001-36014 | 261220025 | 34 | 332170 | 1 | 1 |
| 2026-07-10 | 4 | FORM 4 | 0001439222-26-000112 | 7070 | ||||||
| 2026-07-02 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-080304 | 005-87570 | 261150939 | 34 | 21630 | |||
| 2026-07-02 | 4 | FORM 4 | 0001439222-26-000110 | 8992 | ||||||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000108 | 001-36014 | 261145165 | 33 | 5011 | |||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000107 | 11588 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000105 | 11581 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000103 | 12306 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000101 | 11636 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000099 | 11576 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000097 | 11768 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000095 | 11543 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000093 | 11570 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000091 | 8249 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000089 | 8251 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000087 | 8227 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000085 | 8223 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000083 | 8253 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000081 | 8262 | ||||||
| 2026-06-23 | 4 | FORM 4 | 0001439222-26-000079 | 7963 | ||||||
| 2026-06-18 | S-8 | S-8 | 0001193125-26-275895 | 333-296899 | 261102773 | 33 | 261739 | 1 | 1 | |
| 2026-06-18 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-275879 | 001-36014 | 261102692 | 34 | 154118 | 1 | 1 |
| 2026-06-16 | 4 | FORM 4 | 0001439222-26-000077 | 7335 | ||||||
| 2026-06-16 | 4 | FORM 4 | 0001439222-26-000075 | 7148 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002118 | 005-87570 | 26983978 | 34 | 10597 | |||
| 2026-05-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-002289 | 005-87570 | 26948801 | 34 | 14999 | |||
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000131 | 005-87570 | 26917026 | 34 | 7413 | |||
| 2026-04-29 | 10-Q | 10-Q | 0001439222-26-000073 | 001-36014 | 26910950 | 34 | 5817733 | 1 | 1 | |
| 2026-04-29 | 8-K | 8-K | 2.02,9.01 | 0001439222-26-000071 | 001-36014 | 26910363 | 34 | 312660 | 1 | 1 |
| 2026-04-24 | ARS | ARS | 0001193125-26-177164 | 001-36014 | 26893704 | 34 | 13707310 | |||
| 2026-04-24 | DEFA14A | DEFA14A | 0001193125-26-177092 | 001-36014 | 26893501 | 34 | 512396 | |||
| 2026-04-24 | DEF 14A | DEF 14A | 0001193125-26-177086 | 001-36014 | 26893455 | 34 | 4995838 | 1 | 1 | |
| 2026-04-06 | 4 | FORM 4 | 0001439222-26-000067 | 9382 | ||||||
| 2026-04-06 | 4 | FORM 4 | 0001439222-26-000065 | 9541 | ||||||
| 2026-04-06 | 4 | FORM 4 | 0001439222-26-000063 | 9571 | ||||||
| 2026-04-06 | 4 | FORM 4 | 0001439222-26-000061 | 9419 | ||||||
| 2026-04-06 | 4 | FORM 4 | 0001439222-26-000059 | 9406 | ||||||
| 2026-04-06 | 4 | FORM 4 | 0001439222-26-000057 | 15295 | ||||||
| 2026-04-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000055 | 001-36014 | 26833508 | 33 | 5108 | |||
| 2026-04-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000054 | 001-36014 | 26833419 | 33 | 5054 | |||
| 2026-04-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000053 | 001-36014 | 26833358 | 33 | 5081 | |||
| 2026-04-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000052 | 001-36014 | 26833257 | 33 | 5651 | |||
| 2026-04-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000051 | 001-36014 | 26833224 | 33 | 5057 | |||
| 2026-04-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000050 | 001-36014 | 26833178 | 33 | 5057 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000536 | 005-87570 | 26797378 | 34 | 7179 | |||
| 2026-03-09 | 4 | FORM 4 | 0001439222-26-000049 | 8885 | ||||||
| 2026-03-05 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000047 | 001-36014 | 26726527 | 33 | 4487 | |||
| 2026-03-05 | 4 | FORM 4 | 0001439222-26-000046 | 4628 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001439222-26-000044 | 24349 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001439222-26-000042 | 29071 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001439222-26-000040 | 26311 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001439222-26-000038 | 29098 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001439222-26-000036 | 18862 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001439222-26-000034 | 22247 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001439222-26-000032 | 7870 | ||||||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000030 | 001-36014 | 26707679 | 33 | 5108 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000029 | 001-36014 | 26707635 | 33 | 5056 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000028 | 001-36014 | 26707604 | 33 | 5056 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000027 | 001-36014 | 26707560 | 33 | 5053 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000026 | 001-36014 | 26707509 | 33 | 5650 | |||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001266 | 005-87570 | 26645134 | 34 | 10440 | |||
| 2026-02-12 | S-3ASR | S-3ASR | 0001193125-26-048780 | 333-293421 | 26626479 | 33 | 1345053 | 1 | 1 | |
| 2026-02-12 | 10-K | 10-K | 0001439222-26-000025 | 001-36014 | 26623809 | 34 | 20171716 | 1 | 1 | |
| 2026-02-12 | 8-K | 8-K | 2.02,9.01 | 0001439222-26-000023 | 001-36014 | 26623268 | 34 | 371155 | 1 | 1 |
| 2026-02-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000908834-26-000066 | 005-87570 | 26609756 | 34 | 61592 | |||
| 2026-02-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-26-000018 | 005-87570 | 26609482 | 34 | 8022 | |||
| 2026-01-12 | 8-K | 8-K | 7.01,9.01 | 0001439222-26-000018 | 001-36014 | 26524652 | 34 | 4546954 | 1 | 1 |
| 2026-01-07 | 4 | FORM 4 | 0001439222-26-000013 | 8902 | ||||||
| 2026-01-05 | 144 | xsl144X01/primary_doc.xml | 0001439222-26-000011 | 001-36014 | 26505873 | 33 | 5062 | |||
| 2026-01-02 | 4 | FORM 4 | 0001439222-26-000010 | 9244 | ||||||
| 2026-01-02 | 4 | FORM 4 | 0001439222-26-000008 | 15162 | ||||||
| 2026-01-02 | 4 | FORM 4 | 0001439222-26-000006 | 9242 | ||||||
| 2026-01-02 | 4 | FORM 4 | 0001439222-26-000004 | 9281 | ||||||
| 2026-01-02 | 4 | FORM 4 | 0001439222-26-000002 | 9433 | ||||||
| 2025-12-30 | 144 | xsl144X01/primary_doc.xml | 0001439222-25-000126 | 001-36014 | 251614515 | 33 | 4524 | |||
| 2025-12-30 | 144 | xsl144X01/primary_doc.xml | 0001439222-25-000125 | 001-36014 | 251614494 | 33 | 6228 | |||
| 2025-12-30 | 144 | xsl144X01/primary_doc.xml | 0001439222-25-000124 | 001-36014 | 251614471 | 33 | 4467 | |||
| 2025-12-30 | 144 | xsl144X01/primary_doc.xml | 0001439222-25-000122 | 001-36014 | 251614415 | 33 | 4504 | |||
| 2025-12-30 | 144 | xsl144X01/primary_doc.xml | 0001439222-25-000121 | 001-36014 | 251614392 | 33 | 4472 | |||
| 2025-12-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-118951 | 005-87570 | 251554056 | 34 | 9449 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112633 | 005-87570 | 251487293 | 34 | 12662 | |||
| 2025-11-14 | 4 | FORM 4 | 0001439222-25-000120 | 8284 | ||||||
| 2025-11-13 | 4 | FORM 4 | 0001439222-25-000118 | 8894 | ||||||
| 2025-11-12 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-008736 | 001-36014 | 251470390 | 33 | 6326 | |||
| 2025-11-03 | 4 | FORM 4 | 0001881190-25-000004 | 8437 | ||||||
| 2025-10-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-008305 | 001-36014 | 251436896 | 33 | 5491 | |||
| 2025-10-30 | 10-Q | 10-Q | 0001439222-25-000116 | 001-36014 | 251432640 | 34 | 6529920 | 1 | 1 | |
| 2025-10-30 | 8-K | 8-K | 2.02,9.01 | 0001439222-25-000114 | 001-36014 | 251432060 | 34 | 386002 | 1 | 1 |
| 2025-10-29 | 4 | FORM 4 | 0001439222-25-000111 | 9055 | ||||||
| 2025-10-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-008210 | 001-36014 | 251420307 | 33 | 4809 | |||
| 2025-10-10 | 4 | FORM 4 | 0001439222-25-000108 | 8281 | ||||||
| 2025-10-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007829 | 001-36014 | 251382331 | 33 | 6812 | |||
| 2025-10-02 | 4 | FORM 4 | 0001439222-25-000106 | 8281 | ||||||
| 2025-09-30 | 4 | FORM 4 | 0001439222-25-000104 | 8898 | ||||||
| 2025-09-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007588 | 001-36014 | 251361179 | 33 | 6132 | |||
| 2025-09-26 | 144 | xsl144X01/primary_doc.xml | 0001840056-25-000004 | 001-36014 | 251350787 | 33 | 4468 | |||
| 2025-09-09 | 4 | FORM 4 | 0001439222-25-000102 | 4629 | ||||||
| 2025-08-29 | 4 | FORM 4 | 0001439222-25-000100 | 8281 | ||||||
| 2025-08-28 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-084792 | 005-87570 | 251274012 | 34 | 16226 | |||
| 2025-08-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006426 | 001-36014 | 251265373 | 33 | 5449 | |||
| 2025-08-13 | 4 | FORM 4 | 0001439222-25-000098 | 6901 | ||||||
| 2025-08-13 | 4 | FORM 4 | 0001439222-25-000097 | 6900 | ||||||
| 2025-08-12 | 4 | FORM 4 | 0001439222-25-000093 | 8889 | ||||||
| 2025-08-08 | 144 | xsl144X01/primary_doc.xml | 0001900772-25-000010 | 001-36014 | 251199754 | 33 | 5109 | |||
| 2025-08-04 | 8-K | 8-K | 7.01 | 0001439222-25-000090 | 001-36014 | 251179279 | 34 | 153635 | 1 | 1 |
| 2025-07-31 | 10-Q | 10-Q | 0001439222-25-000089 | 001-36014 | 251170062 | 34 | 6235605 | 1 | 1 | |
| 2025-07-31 | 8-K | 8-K | 2.02,9.01 | 0001439222-25-000087 | 001-36014 | 251169239 | 34 | 320105 | 1 | 1 |
| 2025-07-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002989 | 005-87570 | 251132135 | 34 | 11079 | |||
| 2025-07-15 | 4 | FORM 4 | 0001439222-25-000084 | 8285 | ||||||
| 2025-07-11 | 4 | FORM 4 | 0001439222-25-000082 | 10751 | ||||||
| 2025-07-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-004966 | 001-36014 | 251116975 | 33 | 4764 | |||
| 2025-07-10 | 4 | FORM 4 | 0001439222-25-000080 | 7825 | ||||||
| 2025-07-10 | 3 | FORM 3 | 0001439222-25-000078 | 408935 | ||||||
| 2025-07-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-004940 | 001-36014 | 251114164 | 33 | 6182 | |||
| 2025-07-08 | 8-K | 8-K | 5.02 | 0001439222-25-000076 | 001-36014 | 251109513 | 34 | 148693 | 1 | 1 |
| 2025-07-07 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-066212 | 005-87570 | 251109288 | 34 | 8931 | |||
| 2025-07-03 | 4 | FORM 4 | 0001439222-25-000073 | 8858 | ||||||
| 2025-07-01 | 144 | xsl144X01/primary_doc.xml | 0001900772-25-000007 | 001-36014 | 251096256 | 33 | 4948 | |||
| 2025-06-26 | 4 | FORM 4 | 0001439222-25-000071 | 9242 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001439222-25-000069 | 9240 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001439222-25-000067 | 9270 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001439222-25-000065 | 9279 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001439222-25-000063 | 15155 | ||||||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0001900772-25-000006 | 001-36014 | 251069215 | 33 | 4415 | |||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0001900772-25-000005 | 001-36014 | 251069159 | 33 | 4366 | |||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0001900772-25-000004 | 001-36014 | 251069072 | 33 | 4358 | |||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0001900772-25-000003 | 001-36014 | 251068981 | 33 | 4355 | |||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0001900772-25-000002 | 001-36014 | 251068918 | 33 | 4363 | |||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000061 | 11429 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000059 | 11436 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000057 | 12164 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000055 | 11494 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000053 | 11434 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000051 | 11625 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000049 | 11401 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001439222-25-000047 | 11412 | ||||||
| 2025-06-18 | S-8 | S-8 | 0001193125-25-142763 | 333-288151 | 251057489 | 33 | 292463 | 1 | 1 | |
| 2025-06-18 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-25-142745 | 001-36014 | 251057369 | 34 | 151877 | 1 | 1 |
| 2025-06-17 | 4 | FORM 4 | 0001439222-25-000045 | 7014 | ||||||
| 2025-06-17 | 4 | FORM 4 | 0001439222-25-000043 | 7201 | ||||||
| 2025-06-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-059295 | 005-87570 | 251045875 | 34 | 9461 | |||
| 2025-05-01 | 10-Q | 10-Q | 0001439222-25-000036 | 001-36014 | 25900288 | 34 | 5813804 | 1 | 1 | |
| 2025-05-01 | 8-K | 8-K | 2.02,9.01 | 0001439222-25-000034 | 001-36014 | 25899206 | 34 | 315738 | 1 | 1 |
| 2025-04-25 | ARS | ARS | 0001193125-25-096748 | 001-36014 | 25873946 | 34 | 1844479 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0001193125-25-096729 | 001-36014 | 25873785 | 34 | 193102 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0001193125-25-096719 | 001-36014 | 25873726 | 34 | 4268493 | 1 | 1 | |
| 2025-04-10 | 4 | FORM 4 | 0001439222-25-000029 | 8879 | ||||||
| 2025-04-08 | 144 | xsl144X01/primary_doc.xml | 0001957180-25-000014 | 001-36014 | 25823161 | 33 | 4368 | |||
| 2025-03-07 | 4 | FORM 4 | 0001439222-25-000027 | 7898 | ||||||
| 2025-03-07 | 3 | FORM 3 | 0001439222-25-000025 | 440703 | ||||||
| 2025-03-05 | S-8 | S-8 | 0001193125-25-047359 | 333-285585 | 25712550 | 33 | 445190 | 1 | 1 | |
| 2025-03-04 | 4 | FORM 4 | 0001439222-25-000021 | 26486 | ||||||
| 2025-03-04 | 4 | FORM 4 | 0001439222-25-000019 | 21038 | ||||||
| 2025-03-04 | 4 | FORM 4 | 0001439222-25-000017 | 13383 | ||||||
| 2025-03-04 | 4 | FORM 4 | 0001439222-25-000015 | 18867 | ||||||
| 2025-03-04 | 4 | FORM 4 | 0001439222-25-000013 | 24482 | ||||||
| 2025-03-04 | 4 | FORM 4 | 0001439222-25-000011 | 24437 | ||||||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001957180-25-000013 | 001-36014 | 25698882 | 33 | 4960 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001957180-25-000012 | 001-36014 | 25698856 | 33 | 4378 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001957180-25-000010 | 001-36014 | 25698820 | 33 | 4426 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001957180-25-000009 | 001-36014 | 25698781 | 33 | 4368 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001957180-25-000008 | 001-36014 | 25698758 | 33 | 4370 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-013933 | 005-87570 | 25626904 | 34 | 9078 | |||
| 2025-02-13 | 10-K | 10-K | 0001439222-25-000009 | 001-36014 | 25617619 | 34 | 11585055 | 1 | 1 | |
| 2025-02-13 | 8-K | 8-K | 2.02,9.01 | 0001439222-25-000007 | 001-36014 | 25617088 | 34 | 335669 | 1 | 1 |
| 2025-02-13 | 8-K | 8-K | 5.02 | 0001193125-25-025524 | 001-36014 | 25616955 | 34 | 139217 | 1 | 1 |
| 2025-02-05 | 4 | FORM 4 | 0001439222-25-000004 | 8881 | ||||||
| 2025-02-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000908834-25-000038 | 005-87570 | 25586327 | 34 | 57955 | 1 | 1 | |
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-004943 | 001-36014 | 25524747 | 34 | 3936839 | 1 | 1 |
| 2025-01-07 | 4 | FORM 4 | 0001439222-25-000002 | 8912 | ||||||
| 2025-01-06 | 8-K | 8-K | 7.01 | 0001193125-25-001809 | 001-36014 | 25508991 | 34 | 143856 | 1 | 1 |
| 2025-01-03 | 144 | xsl144X01/primary_doc.xml | 0001957180-25-000002 | 001-36014 | 25506685 | 33 | 4372 | |||
| 2024-12-13 | 4 | FORM 4 | 0001439222-24-000146 | 8291 | ||||||
| 2024-11-14 | SC 13G/A | armistice-agio093024a2.htm | 0001172661-24-005116 | 005-87570 | 241461187 | 34 | 90770 | |||
| 2024-11-13 | 4 | FORM 4 | 0001439222-24-000144 | 4804 | ||||||
| 2024-11-12 | 4 | FORM 4 | 0001439222-24-000142 | 19741 | ||||||
| 2024-11-12 | 4 | FORM 4 | 0001439222-24-000140 | 7234 | ||||||
| 2024-11-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-008290 | 001-36014 | 241440861 | 33 | 5485 | |||
| 2024-11-08 | SC 13G/A | agios_13ga.htm | 0000908834-24-000295 | 005-87570 | 241439992 | 34 | 432498 | |||
| 2024-11-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-008262 | 001-36014 | 241436767 | 33 | 4799 | |||
| 2024-11-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-008213 | 001-36014 | 241435572 | 33 | 8944 | |||
| 2024-10-31 | 10-Q | 10-Q | 0001439222-24-000138 | 001-36014 | 241412729 | 34 | 6496656 | 1 | 1 | |
| 2024-10-31 | 8-K | 8-K | 2.02,9.01 | 0001439222-24-000136 | 001-36014 | 241412366 | 34 | 332961 | 1 | 1 |
| 2024-09-30 | 4 | FORM 4 | 0001439222-24-000129 | 9090 | ||||||
| 2024-08-13 | 4 | FORM 4 | 0001439222-24-000127 | 6910 | ||||||
| 2024-08-13 | 4 | FORM 4 | 0001439222-24-000125 | 6893 | ||||||
| 2024-08-12 | 4 | FORM 4 | 0001439222-24-000123 | 8903 | ||||||
| 2024-08-08 | 144 | xsl144X01/primary_doc.xml | 0001578200-24-000005 | 001-36014 | 241188328 | 33 | 5049 | |||
| 2024-08-01 | 10-Q | 10-Q | 0001439222-24-000121 | 001-36014 | 241164807 | 34 | 6347203 | 1 | 1 | |
| 2024-08-01 | 8-K | 8-K | 2.02,9.01 | 0001439222-24-000117 | 001-36014 | 241164173 | 34 | 335493 | 1 | 1 |
| 2024-07-03 | 4 | FORM 4 | 0001439222-24-000111 | 8867 | ||||||
| 2024-07-01 | 144 | xsl144X01/primary_doc.xml | 0001546216-24-000008 | 001-36014 | 241090689 | 33 | 4406 | |||
| 2024-06-24 | UPLOAD | filename1.pdf | 0000000000-24-007133 | 001-36014 | 39795 | |||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000109 | 7856 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000108 | 7775 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000107 | 7802 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000106 | 7792 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000105 | 7820 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000104 | 7797 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000103 | 7798 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000102 | 7854 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001439222-24-000101 | 7764 | ||||||
| 2024-06-20 | 8-K | 8-K | 5.07 | 0001193125-24-164555 | 001-36014 | 241057361 | 34 | 152046 | 1 | 1 |
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000091 | 9217 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000089 | 7031 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000087 | 8801 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000085 | 6965 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000083 | 6948 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000081 | 6971 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000079 | 6938 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000077 | 7017 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001439222-24-000075 | 7021 | ||||||
| 2024-06-11 | CORRESP | filename1.htm | 0001193125-24-159247 | 38858 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001439222-24-000073 | 9315 | ||||||
| 2024-06-05 | 144 | xsl144X01/primary_doc.xml | 0001546216-24-000006 | 001-36014 | 241023551 | 33 | 5048 | |||
| 2024-06-05 | 4 | FORM 4 | 0001439222-24-000071 | 4637 | ||||||
| 2024-05-30 | UPLOAD | filename1.pdf | 0000000000-24-006246 | 001-36014 | 47126 | |||||
| 2024-05-28 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-147583 | 001-36014 | 24986255 | 34 | 169078 | 1 | 1 |
| 2024-05-02 | 10-Q | 10-Q | 0001439222-24-000069 | 001-36014 | 24905690 | 34 | 5505806 | 1 | 1 | |
| 2024-05-02 | 8-K | 8-K | 2.02,9.01 | 0001439222-24-000067 | 001-36014 | 24905208 | 34 | 295292 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0001193125-24-117998 | 001-36014 | 24883680 | 34 | 2203989 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0001193125-24-117966 | 001-36014 | 24883512 | 34 | 435587 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001193125-24-117951 | 001-36014 | 24883432 | 34 | 4297031 | 1 | 1 | |
| 2024-04-10 | 4 | FORM 4 | 0001439222-24-000063 | 8890 | ||||||
| 2024-03-11 | 4 | FORM 4 | 0001439222-24-000061 | 5274 | ||||||
| 2024-03-07 | 4 | FORM 4 | 0001439222-24-000058 | 7094 | ||||||
| 2024-03-07 | 4 | FORM 4 | 0001439222-24-000056 | 4636 | ||||||
| 2024-03-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-002026 | 001-36014 | 24730522 | 33 | 6776 | |||
| 2024-03-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-001982 | 001-36014 | 24727424 | 33 | 6096 | |||
| 2024-03-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-001926 | 001-36014 | 24723460 | 33 | 5311 | |||
| 2024-03-05 | 4 | FORM 4 | 0001439222-24-000054 | 18996 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001439222-24-000052 | 13586 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001439222-24-000050 | 16772 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001439222-24-000048 | 13375 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001439222-24-000046 | 18998 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001439222-24-000044 | 7890 | ||||||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001546216-24-000004 | 001-36014 | 24710315 | 33 | 5630 | |||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001546216-24-000003 | 001-36014 | 24710289 | 33 | 6160 | |||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001546216-24-000002 | 001-36014 | 24710273 | 33 | 6159 | |||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001546216-24-000001 | 001-36014 | 24710202 | 33 | 4998 | |||
| 2024-02-29 | 4 | FORM 4 | 0001439222-24-000042 | 15711 | ||||||
| 2024-02-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-001483 | 001-36014 | 24688047 | 33 | 6105 | |||
| 2024-02-27 | 4 | FORM 4 | 0001439222-24-000040 | 15715 | ||||||
| 2024-02-26 | 144 | xsl144X01/primary_doc.xml | 0001578200-24-000003 | 001-36014 | 24681591 | 33 | 7055 | |||
| 2024-02-22 | 4 | FORM 4 | 0001439222-24-000037 | 4635 | ||||||
| 2024-02-15 | 10-K | 10-K | 0001439222-24-000035 | 001-36014 | 24642625 | 34 | 11141146 | 1 | 1 | |
| 2024-02-15 | 8-K | 8-K | 2.02,9.01 | 0001439222-24-000032 | 001-36014 | 24642024 | 34 | 320281 | 1 | 1 |
| 2024-02-14 | 4 | FORM 4 | 0001439222-24-000030 | 8876 | ||||||
| 2024-02-14 | 4 | FORM 4 | 0001439222-24-000028 | 8878 | ||||||
| 2024-02-14 | 4 | FORM 4 | 0001439222-24-000026 | 8920 | ||||||
| 2024-02-14 | SC 13G/A | armistice-agio123123a1.htm | 0001172661-24-001214 | 005-87570 | 24636062 | 34 | 90771 | |||
| 2024-02-14 | SC 13G/A | rocksprings-agio123123a1.htm | 0001172661-24-001204 | 005-87570 | 24635901 | 34 | 89675 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-032786 | 005-87570 | 24622464 | 34 | 49538 | |||
| 2024-02-12 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-013960 | 005-87570 | 24618227 | 34 | 13115 | |||
| 2024-02-12 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-013917 | 005-87570 | 24618056 | 34 | 13115 | |||
| 2024-02-08 | SC 13G/A | agio_13ga.htm | 0000908834-24-000046 | 005-87570 | 24607740 | 34 | 434759 | |||
| 2024-01-25 | SC 13G/A | us00847x1046_012524.txt | 0001086364-24-003298 | 005-87570 | 24561078 | 34 | 13641 | |||
| 2024-01-24 | 4 | FORM 4 | 0001439222-24-000022 | 9067 | ||||||
| 2024-01-24 | 4 | FORM 4 | 0001439222-24-000020 | 9065 | ||||||
| 2024-01-24 | 4 | FORM 4 | 0001439222-24-000018 | 9119 | ||||||
| 2024-01-24 | 4 | FORM 4 | 0001439222-24-000016 | 9086 | ||||||
| 2024-01-24 | 4 | FORM 4 | 0001439222-24-000014 | 9318 | ||||||
| 2024-01-24 | 4 | FORM 4 | 0001439222-24-000012 | 9108 | ||||||
| 2024-01-22 | SC 13G/A | Agios_Pharmaceuticals_Inc.txt | 0000093751-24-000059 | 005-87570 | 24547825 | 34 | 8572 | |||
| 2024-01-09 | 4 | FORM 4 | 0001439222-24-000010 | 9330 | ||||||
| 2024-01-09 | 4 | FORM 4 | 0001439222-24-000008 | 9092 | ||||||
| 2024-01-09 | 4 | FORM 4 | 0001439222-24-000006 | 9235 | ||||||
| 2024-01-09 | 4 | FORM 4 | 0001439222-24-000004 | 9233 | ||||||
| 2024-01-08 | 8-K | FORM 8-K | 7.01,9.01 | 0001193125-24-003920 | 001-36014 | 24518373 | 34 | 2974860 | 1 | 1 |
| 2024-01-05 | 4 | FORM 4 | 0001439222-24-000002 | 8912 | ||||||
| 2023-11-09 | SC 13G | agio_13g.htm | 0000908834-23-000146 | 005-87570 | 231393799 | 34 | 445074 | |||
| 2023-11-09 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-23-000049 | 005-87570 | 231391558 | 34 | 32951 | |||
| 2023-11-02 | 10-Q | 10-Q | 0001439222-23-000140 | 001-36014 | 231370382 | 34 | 5985536 | 1 | 1 | |
| 2023-11-02 | 8-K | 8-K | 2.02,9.01 | 0001439222-23-000138 | 001-36014 | 231370006 | 34 | 313178 | 1 | 1 |
| 2023-09-28 | 4 | FORM 4 | 0001439222-23-000133 | 8996 | ||||||
| 2023-08-21 | 4 | FORM 4 | 0001439222-23-000131 | 4967 | ||||||
| 2023-08-15 | 4 | FORM 4 | 0001439222-23-000129 | 6828 | ||||||
| 2023-08-15 | 4 | FORM 4 | 0001439222-23-000127 | 6811 | ||||||
| 2023-08-11 | 4 | FORM 4 | 0001439222-23-000125 | 9205 | ||||||
| 2023-08-10 | 4 | FORM 4 | 0001439222-23-000123 | 8470 | ||||||
| 2023-08-09 | 4 | FORM 4 | 0001439222-23-000121 | 5015 | ||||||
| 2023-08-03 | 10-Q | 10-Q | 0001439222-23-000119 | 001-36014 | 231138344 | 34 | 6075071 | 1 | 1 | |
| 2023-08-03 | 8-K | 8-K | 2.02,9.01 | 0001439222-23-000117 | 001-36014 | 231137939 | 34 | 319867 | 1 | 1 |
| 2023-08-02 | 4 | FORM 4 | 0001439222-23-000113 | 8548 | ||||||
| 2023-07-06 | 4 | FORM 4 | 0001439222-23-000111 | 5511 | ||||||
| 2023-06-30 | 4 | FORM 4 | 0001439222-23-000109 | 8789 | ||||||
| 2023-06-30 | 4 | FORM 4 | 0001439222-23-000107 | 8809 | ||||||
| 2023-06-30 | 4 | FORM 4 | 0001439222-23-000105 | 8787 | ||||||
| 2023-06-30 | 4 | FORM 4 | 0001439222-23-000103 | 8854 | ||||||
| 2023-06-30 | 4 | FORM 4 | 0001439222-23-000101 | 8829 | ||||||
| 2023-06-30 | 4 | FORM 4 | 0001439222-23-000099 | 8824 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001439222-23-000097 | 7871 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001439222-23-000095 | 6893 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001439222-23-000093 | 6860 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001439222-23-000091 | 8723 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000089 | 7829 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000087 | 7833 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000085 | 7774 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000083 | 7682 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000081 | 7772 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000079 | 7710 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000077 | 7715 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000075 | 7693 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001439222-23-000073 | 7738 | ||||||
| 2023-06-15 | 3 | FORM 3 | 0001439222-23-000071 | 407425 | ||||||
| 2023-06-15 | 3 | FORM 3 | 0001439222-23-000069 | 430009 | ||||||
| 2023-06-14 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-166855 | 001-36014 | 231014136 | 34 | 159985 | 1 | 1 |
| 2023-06-13 | S-8 | S-8 | 0001193125-23-166035 | 333-272615 | 231011351 | 33 | 170742 | |||
| 2023-05-25 | 8-K | 8-K | 5.02 | 0001193125-23-154190 | 001-36014 | 23960360 | 34 | 146535 | 1 | 1 |
| 2023-05-04 | 10-Q | 10-Q | 0001439222-23-000065 | 001-36014 | 23886903 | 34 | 5764935 | 1 | 1 | |
| 2023-05-04 | 8-K | 8-K | 2.02,9.01 | 0001439222-23-000063 | 001-36014 | 23886385 | 34 | 325088 | 1 | 1 |
| 2023-04-26 | ARS | ARS | 0001193125-23-118511 | 001-36014 | 23849768 | 34 | 11408488 | |||
| 2023-04-26 | DEFA14A | DEFA14A | 0001193125-23-118499 | 001-36014 | 23849711 | 34 | 41158 | |||
| 2023-04-26 | DEF 14A | DEF 14A | 0001193125-23-118490 | 001-36014 | 23849655 | 34 | 6020899 | 1 | 1 | |
| 2023-04-19 | 8-K | 8-K | 5.02 | 0001193125-23-105679 | 001-36014 | 23828459 | 34 | 146402 | 1 | 1 |
| 2023-04-12 | 4 | FORM 4 | 0001439222-23-000059 | 8299 | ||||||
| 2023-04-10 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-23-000019 | 005-87570 | 23809803 | 34 | 37280 | |||
| 2023-04-05 | 4 | FORM 4 | 0001439222-23-000058 | 11211 | ||||||
| 2023-03-29 | 4 | FORM 4 | 0001439222-23-000056 | 11216 | ||||||
| 2023-03-15 | 4 | FORM 4 | 0001439222-23-000055 | 13077 | ||||||
| 2023-03-07 | 4 | FORM 4 | 0001439222-23-000053 | 4737 | ||||||
| 2023-03-03 | 8-K | 8-K | 5.03,9.01 | 0001193125-23-060031 | 001-36014 | 23704042 | 34 | 308142 | 1 | 1 |
| 2023-03-03 | 4 | FORM 4 | 0001439222-23-000051 | 10669 | ||||||
| 2023-03-03 | 4 | FORM 4 | 0001439222-23-000050 | 7824 | ||||||
| 2023-03-03 | 4 | FORM 4 | 0001439222-23-000049 | 12731 | ||||||
| 2023-03-03 | 4 | FORM 4 | 0001439222-23-000048 | 7810 | ||||||
| 2023-03-03 | 4 | FORM 4 | 0001439222-23-000047 | 12890 | ||||||
| 2023-03-01 | 4 | FORM 4 | 0001439222-23-000041 | 11222 | ||||||
| 2023-02-23 | S-8 | S-8 | 0001193125-23-046628 | 333-269951 | 23659986 | 33 | 71881 | |||
| 2023-02-23 | S-3ASR | S-3ASR | 0001193125-23-046608 | 333-269949 | 23659918 | 33 | 1229787 | |||
| 2023-02-23 | 10-K | 10-K | 0001439222-23-000039 | 001-36014 | 23657200 | 34 | 11447600 | 1 | 1 | |
| 2023-02-23 | 8-K | 8-K | 2.02,9.01 | 0001439222-23-000037 | 001-36014 | 23655877 | 34 | 343541 | 1 | 1 |
| 2023-02-21 | 4 | FORM 4 | 0001439222-23-000028 | 4737 | ||||||
| 2023-02-16 | 4 | FORM 4 | 0001439222-23-000026 | 9826 | ||||||
| 2023-02-16 | 4 | FORM 4 | 0001439222-23-000025 | 8253 | ||||||
| 2023-02-16 | 4 | FORM 4 | 0001439222-23-000024 | 8270 | ||||||
| 2023-02-15 | 4 | FORM 4 | 0001439222-23-000020 | 11222 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-039104 | 005-87570 | 23629232 | 34 | 52000 | |||
| 2023-02-14 | 4 | FORM 4 | 0001439222-23-000018 | 8256 | ||||||
| 2023-02-14 | 4 | FORM 4 | 0001439222-23-000017 | 8254 | ||||||
| 2023-02-14 | 4 | FORM 4 | 0001439222-23-000016 | 10644 | ||||||
| 2023-02-14 | SC 13G | rocksprings-agio123122.htm | 0001172661-23-001245 | 005-87570 | 23627498 | 34 | 89315 | |||
| 2023-02-14 | SC 13G/A | agio13gadec22.txt | 0000080255-23-002609 | 005-87570 | 34 | 7106 | ||||
| 2023-02-14 | SC 13G | armistice-agio123122.htm | 0001172661-23-001035 | 005-87570 | 23625084 | 34 | 90658 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015222 | 005-87570 | 23602172 | 34 | 13033 | |||
| 2023-02-08 | SC 13G/A | Agios_Pharmaceuticals_Inc.txt | 0000093751-23-000336 | 005-87570 | 23597321 | 34 | 8490 | |||
| 2023-02-06 | SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000066 | 005-87570 | 23590017 | 34 | 37293 | |||
| 2023-02-03 | 5 | FORM 5 | 0001439222-23-000012 | 4745 | ||||||
| 2023-02-01 | 4 | FORM 4 | 0001439222-23-000010 | 13077 | ||||||
| 2023-01-25 | SC 13G/A | us00847x1046_012523.txt | 0001306550-23-003493 | 005-87570 | 23550537 | 34 | 13494 | |||
| 2023-01-19 | 4 | FORM 4 | 0001439222-23-000008 | 13078 | ||||||
| 2023-01-18 | 4 | FORM 4 | 0001439222-23-000006 | 5545 | ||||||
| 2023-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-004143 | 001-36014 | 23516553 | 34 | 13508696 | 1 | 1 |
| 2023-01-05 | 4 | FORM 4 | 0001439222-23-000004 | 7831 | ||||||
| 2023-01-05 | 3 | FORM 3 | 0001439222-23-000002 | 7479 | ||||||
| 2023-01-03 | S-8 | S-8 | 0001193125-23-000881 | 333-269108 | 23503315 | 33 | 269921 | |||
| 2022-12-28 | 4 | FORM 4 | 0001439222-22-000105 | 8378 | ||||||
| 2022-12-28 | 4 | FORM 4 | 0001439222-22-000104 | 8215 | ||||||
| 2022-12-16 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-307300 | 001-36014 | 221467896 | 34 | 142569 | 1 | 1 |
| 2022-12-06 | 4 | FORM 4 | 0001439222-22-000101 | 8406 | ||||||
| 2022-12-06 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-298895 | 001-36014 | 221446707 | 34 | 175865 | 1 | 1 |
| 2022-11-03 | 10-Q | 10-Q | 0001439222-22-000099 | 001-36014 | 221356637 | 34 | 6802675 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0001439222-22-000098 | 001-36014 | 221356133 | 34 | 349541 | 1 | 1 |
| 2022-10-27 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-270979 | 001-36014 | 221337559 | 34 | 181015 | 1 | 1 |
| 2022-10-18 | 4 | FORM 4 | 0001439222-22-000091 | 8372 | ||||||
| 2022-10-07 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-259591 | 001-36014 | 221300809 | 34 | 249072 | 1 | 1 |
| 2022-10-06 | SC 13G/A | FILING AGIOS PHARMACEUTICALS, INC. | 0000019617-22-000474 | 005-87570 | 34 | 89886 | ||||
| 2022-09-28 | 4 | FORM 4 | 0001439222-22-000089 | 7850 | ||||||
| 2022-09-28 | 3 | FORM 3 | 0001439222-22-000087 | 7473 | ||||||
| 2022-09-26 | S-8 | S-8 | 0001193125-22-251376 | 333-267624 | 221266650 | 33 | 258507 | |||
| 2022-09-19 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-246740 | 001-36014 | 221249360 | 34 | 178064 | 1 | 1 |
| 2022-09-12 | SC 13G/A | filing.txt | 0000315066-22-001754 | 005-87570 | 221237946 | 34 | 8107 | |||
| 2022-09-07 | 8-K | 8-K | 5.02 | 0001193125-22-239454 | 001-36014 | 221229900 | 34 | 138375 | 1 | 1 |
| 2022-08-15 | 4 | FORM 4 | 0001439222-22-000085 | 7763 | ||||||
| 2022-08-15 | 4 | FORM 4 | 0001439222-22-000084 | 7780 | ||||||
| 2022-08-15 | 3 | FORM 3 | 0001439222-22-000083 | 7405 | ||||||
| 2022-08-15 | 3 | FORM 3 | 0001439222-22-000081 | 7422 | ||||||
| 2022-08-15 | 8-K | 8-K | 5.02 | 0001193125-22-221224 | 001-36014 | 221165947 | 34 | 143300 | 1 | 1 |
| 2022-08-09 | 3/A | FORM 3/A | 0001439222-22-000076 | 7523 | ||||||
| 2022-08-09 | 4 | FORM 4 | 0001439222-22-000074 | 7816 | ||||||
| 2022-08-09 | 3 | FORM 3 | 0001439222-22-000072 | 3167 | ||||||
| 2022-08-08 | S-8 | S-8 | 0001193125-22-215092 | 333-266675 | 221145609 | 33 | 93908 | |||
| 2022-08-04 | 10-Q | 10-Q | 0001439222-22-000070 | 001-36014 | 221135159 | 34 | 6945415 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-211808 | 001-36014 | 221134652 | 34 | 228758 | 1 | 1 |
| 2022-07-12 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-192006 | 001-36014 | 221079306 | 34 | 189265 | 1 | 1 |
| 2022-06-23 | 4 | FORM 4 | 0001439222-22-000066 | 7784 |
One latest value per concept from companyfacts (400 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 59.81M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 1.91B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 54.03M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177086 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.24M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177086 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.44M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177086 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 119.92 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177086 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 62.82 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177086 | ||
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 19.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 3.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 1.46M | 2013-12-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192411 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 38.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 3.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 60.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax | USD | -4.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 25,000 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-07 | 0001193125-13-433119 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 2.61B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 16.67M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 6,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001439222-18-000004 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 900,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 48.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables | Allowance for Doubtful Accounts, Premiums and Other Receivables | USD | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001439222-18-000004 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 518,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 8.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | Assets | Assets | USD | 1.06B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 752.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 831.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 63,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 4.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 782.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 508.99M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-01 | 0001439222-17-000009 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 509.51M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-01 | 0001439222-17-000009 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 224.00M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-04-30 | 0001439222-20-000039 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 143.40M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001193125-16-758835 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 370.19M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-31 | 0001439222-19-000021 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 778.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 501.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 277.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-04 | 0001193125-17-157874 |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Securities | 0 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-07 | 0001193125-14-403316 | |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year | security | 92 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-04-30 | 0001439222-20-000039 | |
| us-gaap | AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year | Securities | 62 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001193125-16-758835 | |
| us-gaap | AvailableForSaleSecuritiesNoncurrent | Available-for-sale Securities, Noncurrent | USD | 88.58M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-31 | 0001439222-19-000021 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 873,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 128.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 52.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -32.22M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001439222-19-000004 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 907.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 128.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 39.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Financing Activities, Discontinued Operations | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 |
| us-gaap | CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Investing Activities, Discontinued Operations | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Operating Activities, Discontinued Operations | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 5.99M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 125.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 76.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 59.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 71,000 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001439222-22-000070 | |
| us-gaap | CommonStockValueOutstanding | Common Stock, Value, Outstanding | USD | 76,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -271.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ContractsReceivableClaimsAndUncertainAmounts | Contracts Receivable, Claims and Uncertain Amounts | USD | 7.90M | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-08 | 0001193125-16-675231 | |
| us-gaap | ContractsRevenue | Contracts Revenue (Deprecated 2018-01-31) | USD | 16.82M | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 |
| us-gaap | ContractWithCustomerAssetNet | Contract with Customer, Asset, after Allowance for Credit Loss | USD | 32.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ContractWithCustomerAssetNetCurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Current | USD | 7.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 2.50M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001439222-22-000040 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 61.51M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod | Contract with Customer, Performance Obligation Satisfied in Previous Period | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent | Contract with Customer, Receivable, after Allowance for Credit Loss, Current | USD | 25.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ContractWithCustomerReceivableAllowanceForCreditLoss | Contract with Customer, Receivable, Allowance for Credit Loss | USD | 3.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 115.92M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 19.73M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 6.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 418.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -444,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -426,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 18,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 2.00M | 2008-01-01 | 2009-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001439222-21-000073 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss | USD | 996.16M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001439222-21-000073 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions | security | 156 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | USD | 995.97M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001439222-21-000073 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | USD | 865.83M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001439222-21-000073 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent | USD | 130.14M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001439222-21-000073 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 663.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | DecreaseInRestrictedCash | Decrease in Restricted Cash | USD | 571,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent | Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent | USD | 6,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 | |
| us-gaap | DeferredCompensationShareBasedArrangementsLiabilityCurrent | Deferred Compensation Share-based Arrangements, Liability, Current | USD | 9,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 3.84M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 306,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-04-30 | 0001439222-20-000039 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 491,000 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-30 | 0001439222-20-000059 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 124.18M | 2018-01-01 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001439222-18-000014 | |
| us-gaap | DeferredRevenueAdditions | Deferred Revenue, Additions | USD | 121.20M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 41.13M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001439222-18-000014 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 72.41M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001439222-18-000014 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 13.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 373.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 86.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 8.41M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 1.25M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 | |
| us-gaap | DeferredTaxAssetsNetNoncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | USD | 2.71M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 134.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 325,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 103.91M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 18.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves | USD | 8.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 365.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 8.41M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 244.90M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001439222-25-000009 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 7.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 418,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 1.00M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | Depreciation | Depreciation | USD | 5.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 8.09M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 |
| us-gaap | DiscontinuedOperationTaxEffectOfDiscontinuedOperation | Discontinued Operation, Tax Effect of Discontinued Operation | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001439222-22-000099 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 | |
| us-gaap | DividendsPayableCurrentAndNoncurrent | Dividends Payable | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 | |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 4.84M | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001439222-17-000007 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -4.46 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -4.74 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -4.46 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.23 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0.006 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.017 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.001 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | 0.001 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.019 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.015 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 19.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 4.00M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-01 | 0001439222-17-000009 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 10.00M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-01 | 0001439222-17-000009 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-01 | 0001439222-17-000009 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-01 | 0001439222-17-000009 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | USD | 0 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-04 | 0001193125-17-157874 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001439222-25-000009 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 | |
| us-gaap | FinancingReceivableAllowanceForCreditLosses | Financing Receivable, Allowance for Credit Loss | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001439222-20-000069 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -1.05M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 2.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | GainOnSaleOfInvestments | Gain on Sale of Investments | USD | 28,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001439222-23-000140 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 88.90M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001439222-22-000099 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -352.09M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -413.81M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -413.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 9,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -327.45M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -6.33 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -6.33 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 43.15M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001439222-25-000009 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 328,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 3.84M | 2014-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 | |
| us-gaap | IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear | Income Tax Examination, Increase (Decrease) in Liability from Prior Year | USD | 700,000 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192411 | |
| us-gaap | IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority | Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority | USD | -400,000 | 2014-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001193125-15-370225 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 700,000 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 1.50M | 2014-01-01 | 2014-01-31 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001193125-16-758835 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -1.02M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 95.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -86.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 592,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 7.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -863,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -153,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 6.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | 0 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001439222-18-000014 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 984,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 14.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -7.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | 7.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0001439222-23-000065 |
| us-gaap | IncreaseDecreaseInDeferredCharges | Increase (Decrease) in Deferred Charges | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -10.64M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001439222-18-000014 |
| us-gaap | IncreaseDecreaseInDueFromRelatedPartiesCurrent | Increase (Decrease) in Due from Related Parties, Current | USD | -44,000 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001439222-17-000007 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 4.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -13.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInOtherDeferredLiability | Increase (Decrease) in Other Deferred Liability | USD | -55,000 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 150,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -790,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001439222-23-000140 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 7.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 2.76M | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-07 | 0001193125-14-403316 |
| us-gaap | IncreaseDecreaseInUnbilledReceivables | Increase (Decrease) in Unbilled Receivables | USD | -476,000 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 29.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | InterestRevenueExpenseNet | Interest Revenue (Expense), Net | USD | 504,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001439222-21-000073 |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 2.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | InventoryGross | Inventory, Gross | USD | 37.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 37.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 5.60M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-07-30 | 0001439222-26-000118 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 374,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 34.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 12.79M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 16.34M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001439222-23-000119 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 11.40M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | LeaseIncentiveReceivable | Lease Incentive Receivable | USD | 20.50M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 27.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 20.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 3.48M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 3.48M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001439222-25-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-04-29 | 0001439222-26-000073 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 3.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceived | Lessor, Operating Lease, Payments to be Received | USD | 1.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths | Lessor, Operating Lease, Payment to be Received, Year One | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear | Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year | USD | 260,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThreeYears | Lessor, Operating Lease, Payment to be Received, Year Three | USD | 67,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedTwoYears | Lessor, Operating Lease, Payment to be Received, Year Two | USD | 178,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 2.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | Liabilities | Liabilities | USD | 84.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.06B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 77.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Liabilities, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-04 | 0001193125-17-157874 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 7.34M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001439222-18-000009 |
| us-gaap | LicenseCosts | License Costs (Deprecated 2018-01-31) | USD | 70,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001439222-22-000040 |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | 5,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 9.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 2.35M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 265.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 239.57M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -235.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -296.06M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -264.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -94.63M | 2021-10-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 456.87M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -297.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 11.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 26.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 19.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 15.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 20.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 9.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 91.29M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 12.76M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 17.14M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 15.55M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 13.47M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 13.13M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 19.22M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 4.99M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.057 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 6.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 4.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | 0 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001439222-17-000007 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax | USD | 2.50M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -4.58M | 2022-07-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001439222-22-000099 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -6.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OtherDepreciationAndAmortization | Other Depreciation and Amortization | USD | 4.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 6,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 240,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 504,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 2.97M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001439222-22-000040 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 3.77M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001439222-22-000099 | |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001439222-22-000099 |
| us-gaap | PaymentsForRepurchaseOfEquity | Payments for Repurchase of Equity | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 2.39M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 933.32M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001439222-19-000004 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 387.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 430.62M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001439222-20-000069 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 3.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 4.16M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 25.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001439222-22-000099 | |
| us-gaap | PreferredStockValueOutstanding | Preferred Stock, Value, Outstanding | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 51.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 113.37M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 77.30M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 12.75M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 9.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 72,000 | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-09-05 | 0001193125-13-358412 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 680.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 448.87M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001439222-20-000069 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecurities | Proceeds from Sale of Available-for-sale Securities | USD | 13.00M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 |
| us-gaap | ProceedsFromSaleOfMachineryAndEquipment | Proceeds from Sale of Machinery and Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 1.32M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001439222-23-000140 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 7.86M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 70.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 10.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 95,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax | USD | 0 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-01 | 0001439222-18-000018 |
| us-gaap | ReimbursementRevenue | Reimbursement Revenue (Deprecated 2018-01-31) | USD | 33.10M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001193125-15-181968 |
| us-gaap | ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 255.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 571,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-18 | 0001193125-14-104521 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 571,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -826.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 120.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 34,000 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 7.34M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001439222-18-000009 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 0 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-02 | 0001439222-19-000009 |
| us-gaap | RevenueRecognitionMultipleDeliverableArrangementsDeterminationOfSellingPriceAmount | Revenue Recognition, Multiple-deliverable Arrangements, Determination of Selling Price, Amount | USD | 124.30M | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 4.50M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001439222-20-000069 | |
| us-gaap | Revenues | Revenues | USD | 30.01M | 2018-10-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001439222-19-000004 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 0 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 |
| us-gaap | RoyaltyIncomeNonoperating | Royalty Income, Nonoperating | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001439222-25-000009 |
| us-gaap | RoyaltyRevenue | Royalty Revenue (Deprecated 2018-01-31) | USD | 2.99M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001439222-18-000014 |
| us-gaap | SecurityDepositLiability | Security Deposit Liability | USD | 200,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 156.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 48.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | USD | 0 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-11-07 | 0001193125-14-403316 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 0 | 2013-01-01 | 2013-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192411 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 7,500 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001439222-18-000004 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.542 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee | Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee | shares | 327,272 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 1.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 4.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 40.88 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 60.40M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 251,567 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 221,212 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 851,777 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 27.26 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-24 | 0001193125-15-060046 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 2.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 6.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 38.34 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 2.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 6.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 38.34 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 30.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 105.27 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 46.28 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 29.98 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 67 | 2018-01-31 | 2018 | Q3 | 10-Q | 2018-11-01 | 0001439222-18-000018 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 979.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 2.75 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 |
| us-gaap | StockholdersEquityOther | Stockholders' Equity, Other | USD | 391,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 19.73M | 2013-07-28 | 2013-07-29 | 2014 | Q3 | 10-Q | 2014-11-07 | 0001193125-14-403316 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 0 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 9.49M | 2019-11-01 | 2019-11-30 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 195,618 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 115.92M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-481973 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 277.20M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001439222-22-000024 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 4.18M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | StockRepurchaseProgramAuthorizedAmount1 | Stock Repurchase Program, Authorized Amount | USD | 1.20B | 2021-03-25 | 2022 | FY | 10-K | 2023-02-23 | 0001439222-23-000039 | |
| us-gaap | StraightLineRent | Straight Line Rent | USD | 24,000 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192411 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 500,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit | Tax Cuts and Jobs Act, Income Tax Expense (Benefit) | USD | 90.00M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001439222-20-000014 |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 3.10M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-16 | 0001193125-17-046795 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 16.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 16.22M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0001439222-23-000065 | |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 802.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 | |
| us-gaap | TreasuryStockValueAcquiredCostMethod | Treasury Stock, Value, Acquired, Cost Method | USD | 802.49M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001439222-24-000035 |
| us-gaap | UnbilledContractsReceivable | Unbilled Contracts Receivable | USD | 476,000 | 2013-12-31 | 2014 | Q2 | 10-Q | 2014-08-07 | 0001193125-14-300949 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 35.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 2.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 1.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 90.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001439222-26-000025 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 59.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 69.00M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001439222-21-000029 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 59.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001439222-26-000131 |